|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 142.80 SEK | -0.14% |
|
-0.42% | -11.19% |
| 07-07 | Biotage Set for Nasdaq Stockholm Delisting in July | MT |
| 07-07 | Biotage to be delisted from Nasdaq Stockholm | RE |
| Capitalization | 11.43B 1.2B 1.02B 954M 887M 1.64B 103B 1.82B 4.37B 48.12B 4.49B 4.4B 177B | P/E ratio 2025 * |
70x | P/E ratio 2026 * | 41.9x |
|---|---|---|---|---|---|
| Enterprise value | 11B 1.15B 985M 918M 854M 1.58B 98.88B 1.75B 4.21B 46.3B 4.32B 4.23B 170B | EV / Sales 2025 * |
6.23x | EV / Sales 2026 * | 5.7x |
| Free-Float |
99.6% | Yield 2025 * |
1.19% | Yield 2026 * | 1.19% |
More valuation ratios
* Estimated data
More news
Last Transcript: Biotage AB
More recommendations
More press releases
More news
| 1 day | -0.14% | ||
| 1 week | -0.42% | ||
| Current month | -0.21% | ||
| 3 months | +63.20% | ||
| 6 months | -10.19% | ||
| Current year | -11.19% |
| 1 week | 142.1 |  | 143.8 |
| 1 month | 141.1 | | 145 |
| Current year | 81.6 | | 165.3 |
| 1 year | 81.6 | | 202.2 |
| 3 years | 81.6 | | 226.2 |
| 5 years | 81.6 | | 295.6 |
| 10 years | 16.6 | | 295.6 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 58 | 15/09/2024 | |
Andrew Kellett
DFI | Director of Finance/CFO | 57 | 24/09/2023 |
Marc Hummersone
CTO | Chief Tech/Sci/R&D Officer | - | 29/02/2024 |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 73 | 05/11/2019 | |
| Director/Board Member | 70 | - | |
Mark Bradley
BRD | Director/Board Member | 63 | 23/04/2019 |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -0.14% | -0.42% | -15.80% | -30.27% | 1.2B | ||
| -2.43% | +0.64% | -9.41% | -43.66% | 16.04B | ||
| -3.84% | +0.50% | -3.62% | -70.85% | 2.05B | ||
| +0.74% | +20.83% | -23.13% | +199.13% | 1.41B | ||
| +0.71% | +1.22% | -8.73% | - | 1.3B | ||
| -0.88% | +0.43% | +11.82% | -7.12% | 872M | ||
| -1.78% | -1.25% | -7.15% | -39.12% | 860M | ||
| +0.27% | +2.96% | +14.13% | -46.83% | 837M | ||
| -3.38% | -0.54% | -32.35% | -52.16% | 457M | ||
| -4.33% | -7.16% | -44.98% | -60.93% | 339M | ||
| Average | -1.51% | +2.04% | -11.92% | -16.87% | 2.54B | |
| Weighted average by Cap. | -1.98% | +1.75% | -9.27% | -30.12% |
| 2025 * | 2026 * | |
|---|---|---|
| Net sales | 1.77B 185M 158M 147M 137M 253M 15.88B 281M 675M 7.43B 694M 680M 27.27B | 1.89B 198M 169M 158M 147M 271M 16.99B 301M 723M 7.96B 743M 727M 29.18B |
| Net income | 164M 17.18M 14.69M 13.69M 12.73M 23.52M 1.47B 26.14M 62.7M 690M 64.45M 63.12M 2.53B | 275M 28.81M 24.64M 22.95M 21.35M 39.44M 2.47B 43.83M 105M 1.16B 108M 106M 4.25B |
| Net Debt | -433M -45.34M -38.77M -36.11M -33.59M -62.06M -3.89B -68.97M -165M -1.82B -170M -167M -6.68B | -658M -68.9M -58.92M -54.88M -51.04M -94.31M -5.91B -105M -251M -2.77B -258M -253M -10.15B |
More financial data
* Estimated data
Employees
622
Calendar
| Date | Price | Change | Volume |
|---|---|---|---|
| 11/07/25 | 142.80 kr | -0.14% | 57,956 |
| 10/07/25 | 143.00 kr | +0.21% | 4,321 |
| 09/07/25 | 142.70 kr | -0.21% | 67,193 |
| 08/07/25 | 143.00 kr | 0.00% | 59,098 |
| 07/07/25 | 143.00 kr | -0.28% | 102,039 |
Delayed Quote Nasdaq Stockholm, July 11, 2025 at 05:00 pm
More quotes
Sell
Buy
Mean consensus
HOLD
Number of Analysts
1
Last Close Price
142.80SEK
Average target price
143.00SEK
Spread / Average Target
+0.14%
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- BIOT Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition